Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-015659
Filing Date
2022-06-22
Accepted
2022-06-22 19:02:55
Documents
1
Period of Report
2022-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6152
  Complete submission text file 0001437749-22-015659.txt   7513
Mailing Address 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517
Business Address
Cermak Elizabeth (Reporting) CIK: 0001471971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 221033234

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations